Laychiluh Mekonnen
3PUBLICATIONS
11CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (3)
Sort by Publication Date:
|Oct 16, 2025
Cancer Burden Attributable to Potentially Modifiable Risk Factors in Australia.Tenaw Tiruye, Bereket Duko, Laychiluh Mekonnen
|Apr 13, 2023
Discovery of N,4-Di(1H-pyrazol-4-yl)pyrimidin-2-amine-Derived CDK2 Inhibitors as Potential Anticancer Agents: Design, Synthesis, and Evaluation.Biruk Sintayehu Fanta, Jimma Lenjisa, Theodosia Teo
|Feb 04, 2017
Highly Potent, Selective, and Orally Bioavailable 4-Thiazol-N-(pyridin-2-yl)pyrimidin-2-amine Cyclin-Dependent Kinases 4 and 6 Inhibitors as Anticancer Drug Candidates: Design, Synthesis, and Evaluation.Solomon Tadesse, Mingfeng Yu, Laychiluh B Mekonnen
Pageof 1
Frequent Collaborators
2 joint publications
Shudong Wang
1 joint publications
Solomon Tadesse
1 joint publications
Hugo Albrecht
1 joint publications
Biruk Sintayehu Fanta
1 joint publications
Yuchao Yang
1 joint publications
Matthew J Sykes
1 joint publications
Mingfeng Yu
1 joint publications
Bereket Duko
1 joint publications
Paul Ward
1 joint publications
Trang H H D Nguyen
